Comparison of serum Vascular Cell Adhesion Molecule (VCAM) level among epithelial ovarian cancer patients and healthy women

被引:0
|
作者
Hussain, Rizwana [1 ]
Khaliq, Saba [2 ]
机构
[1] Allama Iqbal Med Coll, Dept Physiol, Lahore, Pakistan
[2] Univ Hlth Sci, Dept Physiol, Lahore, Pakistan
关键词
VCAM; FIGO; Correlation; Serum marker; Ovarian cancer; MICRORNA EXPRESSION;
D O I
10.47391/JPMA.9424
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare serum vascular cell adhesion molecule levels among ovarian cancer patients of different standardised grades, and in relation to healthy controls. Method: The case-control study was conducted from 6.2.2018 to 1.8.2021 after approval form the ethics review board of the University of Health Sciences, Lahore, Pakistan, and comprised females aged 20-70 years diagnosed with ovarian cancer and tentatively planned for surgical procedures in group A, and healthy controls in group B. From all the subjects, 2.5ml blood was taken in a green-top tube. The tubes were centrifuged, and the serum was separated within an hour of sample collection. The Eppendorf tubes were labelled and stored at -20 degrees C. The samples were thawed, and, following the manual protocol, they were subjected to vascular cell adhesion molecule enzyme-linked immunosorbent assay. Cancer antigen 125 values before surgery and 6-8 months post-surgery were recorded from available laboratory reports. Also, group A was categorised in line with the International Federation of Gynaecology and Obstetrics stage classification. Data was analysed using SPSS 24. Results: Of the 80 female subjects, 40(50%) were group A cases and 40(50%) were group B controls. The overall mean age was 48 +/- 12 years. Overall, 55(68.7%) women were aged <55 years and 25(31.3%) were aged >55 years. Within group A, 20(50%) had cancer stage I-II and 20(50%) had stage III-IV. Overall median vascular cell adhesion molecule was 72.40ug/L (interquartile range: 1857.40ug/L), with 71.15ug/L (interquartile range: 616.60ug/L) in group A and 74.10ug/L (interquartile range: 1848.70ug/L) in group B. Significant correlation was found between cancer stage and vascular cell adhesion molecule level (rho=0.73; p=0.003). Conclusion: There was a decreased level of vascular cell adhesion molecule level in epithelial ovarian cancer cases compared to healthy controls. A positive association was observed between ovarian cancer stage and vascular cell adhesion molecule level.
引用
收藏
页码:1437 / 1440
页数:4
相关论文
共 50 条
  • [31] Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
    Spizzo, Gilbert
    Went, Philip
    Dirnhofer, Stephan
    Obrist, Peter
    Moch, Holger
    Baeuerle, Patrick A.
    Mueller-Holzner, Elisabeth
    Marth, Christian
    Gastl, Guenther
    Zeimet, Alain G.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 483 - 488
  • [32] Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients
    Sasaki, H
    Auclair, D
    Kaji, M
    Fukai, I
    Kiriyama, M
    Yamakawa, Y
    Fujii, Y
    Chen, LB
    CANCER LETTERS, 2001, 172 (01) : 37 - 42
  • [33] Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer
    Ferdeghini, M
    Gadducci, A
    Prontera, C
    Annicchiarico, C
    Gagetti, O
    Bianchi, M
    Facchini, V
    Genazzani, AR
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2255 - 2260
  • [34] The role of vascular cell adhesion molecule 1 (VCAM-1) in patients with food allergy and chronic gastritis
    Bartuzi, Zbigniew
    Zbikowska-Gotz, Magdalena
    PRZEGLAD GASTROENTEROLOGICZNY, 2007, 2 (05): : 256 - 262
  • [35] Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease
    Diaz-Sanchez, Antonio
    Matilla, Ana
    Nunez, Oscar
    Rincon, Diego
    Lorente, Raquel
    Lo Iacono, Oreste
    Merino, Beatriz
    Hernando, Ana
    Campos, Rocio
    Clemente, Gerardo
    Banares, Rafael
    ANNALS OF HEPATOLOGY, 2013, 12 (02) : 236 - 247
  • [36] JAK/STAT pathway interacts with intercellular cell adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) while prostate cancer stem cells form tumor spheroids
    Duzagac, Fahriye
    Inan, Sevinc
    Simsek, Fatma Ela
    Acikgoz, Eda
    Guven, Ummu
    Khan, Shafiq A.
    Rouhrazi, Hadi
    Oltulu, Fatih
    Aktug, Huseyin
    Erol, Ayse
    Oktem, Gulperi
    JOURNAL OF BUON, 2015, 20 (05): : 1250 - 1257
  • [37] Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X)
    Tousoulis, D
    Davies, GJ
    Asimakopoos, G
    Homaei, H
    Zouridakis, E
    Ahmed, N
    Kaski, JC
    CLINICAL CARDIOLOGY, 2001, 24 (04) : 301 - 304
  • [38] Functional detection of epithelial cell adhesion molecule specific cytotoxic T lymphocytes in patients with lung cancer, colorectal cancer and in healthy donors
    Trojan, A
    Tun-Kyi, A
    Odermatt, B
    Nestle, FO
    Stahel, RA
    LUNG CANCER, 2002, 36 (02) : 151 - 158
  • [39] Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with Rheumatoid Arthritis
    Davies, Ruth
    Iacono, Daniela
    Jordan, Lauren A.
    Williams, Jessica O.
    Rawlings, Charlotte
    Lang, Derek
    Williams, Anwen S.
    Choy, Ernest H.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [40] Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries
    Gonzalez-Palomares, Blanca
    Coronado Martin, Pluvio J.
    Maestro de las Casas, Maria Luisa
    Veganzones de Castro, Silvia
    Rafael Fernandez, Sara
    Vidaurreta Lazaro, Marta
    De la Orden Garcia, Virginia
    Vidart Aragon, Jose Antonio
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1088 - 1095